Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Koup

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|November 7, 1998
A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illnessD A Wilkinson, E A Operskalski, M P Busch, et al.
AIDS (London, England)|June 20, 1998
Genetic and immunological host factors associated with susceptibility to HIV-1 infectionK A Buchacz, D A Wilkinson, J F Krowka, et al.
Journal of Virology|April 3, 1998
CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolatesM C Gauduin, G P Allaway, W C Olson, et al.
Nature Medicine|December 13, 1997
Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1M C Gauduin, P W Parren, R Weir, et al.
Science (New York, N.Y.)|August 27, 1993
Genotypic and phenotypic characterization of HIV-1 patients with primary infectionT Zhu, H Mo, N Wang, et al.
The Journal of Infectious Diseases|September 1, 1993
Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitutionR M Hesselton, R A Koup, M A Cromwell, et al.
Science (New York, N.Y.)|November 8, 1996
Response: HIV-1 Evolution and Disease ProgressionS M Wolinsky, K J Kunstman, J T Safrit, et al.
Journal of Virology|April 1, 1996
Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin moleculesM C Gauduin, G P Allaway, P J Maddon, et al.
The Journal of Infectious Diseases|December 23, 1999
Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1T J Sellati, D A Wilkinson, J S Sheffield, et al.
The Journal of Infectious Diseases|May 9, 2001
RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progressionW A Paxton, A U Neumann, S Kang, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|November 7, 1998
A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illnessD A Wilkinson, E A Operskalski, M P Busch, et al.
AIDS (London, England)|June 20, 1998
Genetic and immunological host factors associated with susceptibility to HIV-1 infectionK A Buchacz, D A Wilkinson, J F Krowka, et al.
Journal of Virology|April 3, 1998
CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolatesM C Gauduin, G P Allaway, W C Olson, et al.
Nature Medicine|December 13, 1997
Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1M C Gauduin, P W Parren, R Weir, et al.
Science (New York, N.Y.)|August 27, 1993
Genotypic and phenotypic characterization of HIV-1 patients with primary infectionT Zhu, H Mo, N Wang, et al.
The Journal of Infectious Diseases|September 1, 1993
Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitutionR M Hesselton, R A Koup, M A Cromwell, et al.
Science (New York, N.Y.)|November 8, 1996
Response: HIV-1 Evolution and Disease ProgressionS M Wolinsky, K J Kunstman, J T Safrit, et al.
Journal of Virology|April 1, 1996
Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin moleculesM C Gauduin, G P Allaway, P J Maddon, et al.
The Journal of Infectious Diseases|December 23, 1999
Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1T J Sellati, D A Wilkinson, J S Sheffield, et al.
The Journal of Infectious Diseases|May 9, 2001
RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progressionW A Paxton, A U Neumann, S Kang, et al.
Pageof 10